Orexigen Therapeutics Inc (OREX)

1.88
0.02 1.10
NASDAQ : Health Care
Prev Close 1.90
Open 1.89
Day Low/High 1.84 / 1.90
52 Wk Low/High 3.49 / 46.40
Volume 30.47K
Avg Volume 130.60K
Exchange NASDAQ
Shares Outstanding 14.59M
Market Cap 27.71M
EPS -5.20
Div & Yield N.A. (N.A)

Latest News

These 5 Stocks Under $10 Are Set to Soar Higher

These 5 Stocks Under $10 Are Set to Soar Higher

Here's a technical look at how to trade several under-$10 stocks that are poised for breakouts.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under -$10 stocks are poised to breakout and trade higher from current levels.

Orexigen Announces South Korean Approval Of Contrave® (naltrexone HCI And Bupropion HCI Extended-Release) Monotherapy For Weight Management In Overweight Or Obese Adult Patients

Orexigen Announces South Korean Approval Of Contrave® (naltrexone HCI And Bupropion HCI Extended-Release) Monotherapy For Weight Management In Overweight Or Obese Adult Patients

Orexigen has shipped the first order of Contrave tablets to partner Kwang Dong in anticipation of a commercial launch later this quarter

Orexigen Announces Strategic Acquisition Of All U.S. Rights To Contrave®, The Market Leading Branded Anti-obesity Prescription Medicine

Orexigen Announces Strategic Acquisition Of All U.S. Rights To Contrave®, The Market Leading Branded Anti-obesity Prescription Medicine

Acquisition magnifies projected long-term corporate profitability and opens multiple paths for shareholder value creation

Orexigen And Takeda Jointly Announce Orexigen's Acquisition Of All Rights To CONTRAVE® In The United States

Orexigen And Takeda Jointly Announce Orexigen's Acquisition Of All Rights To CONTRAVE® In The United States

Acquisition provides Orexigen ownership of CONTRAVE in nearly all major global markets

Orexigen Therapeutics (OREX) Stock Plunges on Q4 Miss

Orexigen Therapeutics (OREX) Stock Plunges on Q4 Miss

Orexigen Therapeutics (OREX) stock is falling on Friday morning after the company posted its 2015 fourth quarter results before today’s market open.

Interesting OREX Put And Call Options For October 21st

Interesting OREX Put And Call Options For October 21st

Investors in Orexigen Therapeutics, Inc. saw new options become available this week, for the October 21st expiration.

8 Stocks Under $10 Making Big Moves Higher

8 Stocks Under $10 Making Big Moves Higher

These stocks trading for less than $10 a share are within range of triggering big breakouts.

Orexigen Therapeutics Stock Sees Short Interest Decline 34%

Orexigen Therapeutics Stock Sees Short Interest Decline 34%

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 13,255,786 share decrease in total short interest for Orexigen Therapeutics, Inc. , to 25,834,405, a decrease of 33.91% since 12/15/2015.

Orexigen Announces 2016 Financial Outlook And Key Priorities

Orexigen Announces 2016 Financial Outlook And Key Priorities

- Focus is managing to profitability by year end 2018

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

Orexigen Therapeutics (OREX) Is Weak On High Volume Today

Orexigen Therapeutics (OREX) Is Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Weak On High Volume: Orexigen Therapeutics (OREX)

Weak On High Volume: Orexigen Therapeutics (OREX)

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

First Week of OREX July 2016 Options Trading

First Week of OREX July 2016 Options Trading

Investors in Orexigen Therapeutics, Inc. saw new options begin trading this week, for the July 2016 expiration.

Orexigen Therapeutics (OREX) Weak On High Volume Today

Orexigen Therapeutics (OREX) Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Strong On High Relative Volume: Orexigen Therapeutics (OREX)

Strong On High Relative Volume: Orexigen Therapeutics (OREX)

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

First Week of December 18th Options Trading For Orexigen Therapeutics (OREX)

First Week of December 18th Options Trading For Orexigen Therapeutics (OREX)

Investors in Orexigen Therapeutics, Inc. saw new options begin trading this week, for the December 18th expiration.